Fundraising FoxScarlet
1 known investors
Find your way into Scarlet
Sign up to see every warm intro you have to Scarlet
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Scarlet team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Scarlet Therapeutics develops a platform that produces lab-grown, universal red blood cell-based therapeutics (tRBCs) engineered to carry high levels of therapeutic proteins for treating a range of diseases. It initially targets rare metabolic diseases such as hyperammonemia and hyperoxaluria, with potential applications in other metabolic diseases, cancer, and autoimmune conditions.
Founders & leadership
AT
Ash ToyeCo-founder, Professor
JF
Jan FrayneCo-founder, Professor
Investors · 1
Frequently asked questions
- What does Scarlet do?
- Scarlet Therapeutics develops a platform that produces lab-grown, universal red blood cell-based therapeutics (tRBCs) engineered to carry high levels of therapeutic proteins for treating a range of diseases. It initially targets rare metabolic diseases such as hyperammonemia and hyperoxaluria, with potential applications in other metabolic diseases, cancer, and autoimmune conditions.
- Who are Scarlet's investors?
- Scarlet's investors include Daft Capital.